Priority HOVON trials

 

Please find below the overview of the upcoming data analysis within HOVON trials. This list is meant for Local Data Managers to review which deadlines there are for certain trials. Of course we hope that it is possible to have  all data up to date and all queries answered within the general timelines as are specified in the eCRF instructions per trial. However in case there is some back log in providing data, this list below can be used to asses for which trial(s) we are most eager to receive your help in completing the data.

If the provided timelines below are not achievable for you, please contact the central data manager (listed at section Participating Parties at each trial) of the concerning trial.


Planned HOVON interim/final analyses for the coming 6 months

Updated:January 2021

(sorted by HOVON study number)

  • HO104 AL amyloidosis: FU analysis (Q2-2021)  
  • HO110 FL : interim analysis (Q3-2021)
  • HO114 MM: Final analysis (Q2-2021)  
  • HO136 NHL: interim analysis (Q3-2021)
  • HO139 CLL: Maintenance final analysis (Q1-2021)  
  • HO141 CLL: Induction final analysis (Q2-2021)
  • HO148 AML/SCT: final analysis (Q1-2021)  
  • HO150 AML: 1st interim analysis IDH2 cohort (1st 50 patients completing induction) (Q1-2021)
  • HO150 AML: 2nd interim analysis IDH2 cohort (1st 100 patients completing induction) (Q2-2021)
  • HO150 AML: 3rd interim analysis IDH2 cohort (1st 50 patients completing consolidation) (Q2-2021)
  • HO150 AML: 1st interim analysis IDH1 cohort (1st 50 patients completing induction) (Q2-2021)
  • HO151 NHL: 2nd interim analysis (Q1-2021)
  • HO152 DLBCL: interim analysis (Q2-2021)      
  • HO159 CLL: 1st interim analysis (Q2/Q3-2021)

      

 

Up